Video Shorts

How Your Feedback Shapes Regulation

The At Risk Decision: When to Move or Stop a Batch

Why Pharma is Partnering for AI, Not Buying

Why Supply Chain Resistance Can Kill M&A Deals

How Lehigh Valley is Prepping a Workforce for Lilly

Why Pharma M&A Dropped In Q1

Why Eli Lilly Chose Pennsylvania for its $3.5B Facility

The Most Important Thing for CDMOs in 2026

Molly Klote’s Biggest Takeaway from CPHI Americas 2026

How Government Leaders Are Thinking About Reshoring

Infrastructure Needs for Radiopharmaceutical Trials

The Importance of Treating HPV

Why FDA Rejections Happen And How to Stop Them

How AI is Revolutionizing Drug Development and Innovation

The Promising Results of TGN-S11

How the Right FDA Strategy Saves Millions

The Just-in-Time Challenge of Cancer Drugs

The Danger of Misaligned Lab Procedures

Navigating the Double-Layer of Cancer Drug Regulations

Why You Must Trend Lab Data

Why Slow-Release Medication is Safer

How to Best Prepare for Drug Shortages

How to Approach the Balancing Act of Pharma Manufacturing

Why Organizations Should Embrace Media & Buffer Manufacturing

The True Benefits of Lean Production

The Most Common Supply Chain Mistake

When Virtual Groups Don't Work

The New Pattern in Clinical Trials

Challenges of Virtual Control Groups

The Truth_The FDA Does Not Approve Excipients